RNAi quashes polyQ

RNA interference in the brain inhibits neurodegeneration in a polyglutamine disease, SCA1. Is this now the way forward for the clinical treatment of certain genetic disorders (pages 816–820)?

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Nixing neurodegeneration.

Renee Lucas

References

  1. 1

    Elbashir, S.M. et al. Nature 411, 494–498 (2001).

  2. 2

    Caplen, N.J., Parrish, S., Imani, F., Fire, A. & Morgan, R.A. Proc. Natl. Acad. Sci. USA 98, 9742–9747 (2001).

  3. 3

    Xia, H. et al. Nat. Med. 8, 816–820 (2004).

  4. 4

    Schols, L., Bauer, P., Schmidt, T., Schulte, T. & Riess, O. Lancet Neurol 3, 291–304 (2004).

  5. 5

    Taylor, J.P., Hardy, J. & Fischbeck, K.H. Science 296, 1991–1995 (2002).

  6. 6

    Paulson, H. Nat. Med. 9, 825–826 (2003).

  7. 7

    Caplen, N.J. Gene Ther. 11, in the press (2004).

  8. 8

    Dykxhoorn, D.M., Novina, C.D. & Sharp, P.A. Nat. Rev. Mol. Cell. Biol. 4, 457–467 (2003).

  9. 9

    Flotte, T. Gene Ther. 11, 805–810 (2004).

  10. 10

    Howard, K. Nat. Biotechnol. 21, 1117–1118 (2003).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Caplen, N. RNAi quashes polyQ. Nat Med 10, 775–776 (2004). https://doi.org/10.1038/nm0804-775

Download citation

Further reading